Japan's Eisai to hike div by 10 yen in 08/09-media
TOKYO, May 13 (Reuters) - Eisai Co (4523.T: Quote, Profile, Research, Stock Buzz), Japan's fourth-largest drugmaker, will hike its annual dividend by 10 yen to 140 yen this business year as it swings back to profit, the Nikkei business daily reported on Tuesday.
Eisai, best known for its Alzheimer's treatment Aricept, has said it would post a net loss for the first time ever in 2007/08 on costs to acquire U.S. cancer specialist MGI Pharma, but it expects a profit of 56 billion yen this business year to March.
Eisai said in a statement that it had not decided on its dividend plan for this year and would announce it on Wednesday along with its earnings results and forecasts. (Reporting by Sachi Izumi; Editing by Chris Gallagher)
© Thomson Reuters 2008 All rights reserved
Ads by Career Builder
Healthcare Center Director
Details: ...healthy.” Community Healthcare Network is a not-for-profit...immediate opening for a Healthcare Center Director...management staff the Healthcare Center Director...
Methodologist, Statistician, Healthcare Market Research
Details: ...Statistician, Healthcare Market Research...opening for a Senior Healthcare Project Manager...expertise to the healthcare division • Building...
Account Manager Healthcare NJ
Details: ...seeking a sales MANIAC to manage accounts in our Healthcare niche. Do you enjoy the thrill of the hunt? Do you...
Healthcare Project Manager
Details: ...premier healthplans in New York We are looking for a seasoned Healthcare Project Manager to join a healthplan team in overseeing the...
Sphere
Rocker Monk
Iran rules out enrichment freeze
